FDA Inspection
Park Avenue CompoundingPark Avenue Compounding – FDA Inspection, Aug 5, 2009
Record Details
This FDA Inspection record concerns Park Avenue Compounding, with an inspection on August 5, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Park Avenue Compounding
- Inspection Date
- August 5, 2009
- Product Type
- Biologics
View Company Profile
ID · 96c546d8-9019-4a0d-9a7d-48b5379c28b4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 609213
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Park Avenue Compounding
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| February 8, 2024 | OAI | Drug Quality Assurance | |
| August 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Park Avenue Compounding
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.